The activation of the RAAS system primarily drives myocardial fibrosis, exerting its biological effects by increasing both anterior and posterior cardiac loads through the release of angiotensin II (Ang II), aldosterone, and other bioactive substances. This evidence concerns the gene AGT and Myocardial fibrosis.